Colts GM: Alec Pierce to Forego Second PRP Injection Amidst Recovery
Indianapolis Colts General Manager Chris Ballard announced that wide receiver Alec Pierce will not receive a second Platelet-Rich Plasma (PRP) injection. This decision comes as Pierce continues to recover from a recent injury.
Indianapolis, IN, August 11, 2026 —
Indianapolis Colts General Manager Chris Ballard stated that wide receiver Alec Pierce will not be receiving a second Platelet-Rich Plasma (PRP) injection. The announcement was made by Ballard as Pierce continues his recovery from a recent injury.
The decision regarding the PRP injection was shared without further specific details on the nature of Pierce’s injury or the timeline for his return to play. Ballard did not provide information regarding the specific injury that led to the need for medical treatment.
Platelet-Rich Plasma (PRP) therapy is a medical treatment that uses a patient’s own blood platelets to accelerate the healing of injured muscles, tendons, and ligaments. The process involves drawing blood from the patient, concentrating the platelets, and then injecting this concentration into the injured area.
The Colts have not detailed whether Pierce has already undergone a first PRP injection or if the decision is to prevent him from receiving one altogether. The exact status of his recovery and any potential impact on his participation in team activities for the upcoming season remain undisclosed. Further updates are expected from the team’s management as Pierce’s recovery progresses.
Story summarized from the original created by Google News on news.google.com, see more information here.
